UK-based Manual is a direct-to-consumer telehealth startup that provides personalized treatments, medication delivery, and clinical support with a focus on common issues related to men’s health such as hair loss, sex health, and skin conditions. Users are asked to fill out a questionnaire to set up a customized treatment plan and the company’s clinicians will determine the appropriate medication based on the answers provided. Once approved, Manual ships the treatment through its 48-hour delivery service. Patients can also take at-home blood tests to analyze heart health, gut health, testosterone, sleep, energy, and immunity. As of March 2021, the company had served more than 50,000 customers.
In addition, Manual provides patient support services where users can directly message the company’s clinicians or schedule a free consultation over the phone. Users can also track the progress of their treatment through the platform. The cost of a member’s subscription is based on the treatment plan.
Manual completed a Series A funding round in March 2021 that brought its total funds raised up to GBP 27 million (USD 37 million). The company plans to enhance its product portfolio and expand into Europe, Asia, and Latin America. The company also operates in Brazil.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.